Company profile
Intellia Therapeutics company profile
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments. It can positively transform the lives of people living with severe and life-threatening diseases. IIntellia holds exclusive access to one of the most comprehensive intellectual property platforms available for the therapeutic use of CRISPR-Cas9. The company is advancing a broad pipeline toward clinical development, including ex Vivo, and in vivo approaches. Intellia Therapeutics was formed in 2014 and is headquartered in Cambridge, Massachusetts.
Business identity
- Website
- http://intelliatx.com
- Contact email
- [email protected]
- Phone number
- (857) 285-6200
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 251-500 employees
- Revenue range
- $50,000+
- Founded
- 2014-01-01, Year
Headquarters
- Headquarters
- Primghar, Iowa, United States
- Postal code
- 02139
- Country code
- US
- Continent
- North America